TS Financial Group (TSFG)’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-9
Closed 748
2024
Q3
$0 Buy
+9
New ﹤0.01% 779